SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-457533
Filing Date
2012-11-07
Accepted
2012-11-07 16:29:12
Documents
13
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398123d10q.htm 10-Q 644938
2 EX-10.1 d398123dex101.htm EX-10.1 430537
3 EX-10.2 d398123dex102.htm EX-10.2 50831
4 EX-31.1 d398123dex311.htm EX-31.1 6866
5 EX-31.2 d398123dex312.htm EX-31.2 6866
6 EX-32.1 d398123dex321.htm EX-32.1 4364
7 EX-32.2 d398123dex322.htm EX-32.2 4346
  Complete submission text file 0001193125-12-457533.txt   4405828

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT srpt-20120930.xml EX-101.INS 537993
9 XBRL TAXONOMY EXTENSION SCHEMA srpt-20120930.xsd EX-101.SCH 38514
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20120930_cal.xml EX-101.CAL 44343
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20120930_def.xml EX-101.DEF 94279
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20120930_lab.xml EX-101.LAB 293286
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20120930_pre.xml EX-101.PRE 205020
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 121187159
SIC: 2834 Pharmaceutical Preparations